Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation

[1]  L. Vallier,et al.  Potential of human induced pluripotent stem cells in studies of liver disease , 2015, Hepatology.

[2]  N. Hanley,et al.  Generation of Distal Airway Epithelium from Multipotent Human Foregut Stem Cells , 2015, Stem cells and development.

[3]  M. Strazzabosco,et al.  Emerging roles of Notch signaling in liver disease , 2015, Hepatology.

[4]  M. Trauner,et al.  Cystic Fibrosis Related Liver Disease—Another Black Box in Hepatology , 2014, International journal of molecular sciences.

[5]  W. Cichy,et al.  Liver disease in cystic fibrosis , 2014, Przeglad gastroenterologiczny.

[6]  L. Combettes,et al.  Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells , 2014, Hepatology.

[7]  M. G. Novaes,et al.  Pathophysiology of cystic fibrosis and drugs used in associated digestive tract diseases. , 2013, World journal of gastroenterology.

[8]  Ludovic Vallier,et al.  Generation of Multipotent Foregut Stem Cells from Human Pluripotent Stem Cells , 2013, Stem cell reports.

[9]  Ludovic Vallier,et al.  Production of hepatocyte-like cells from human pluripotent stem cells , 2013, Nature Protocols.

[10]  N. Chandok.  Polycystic liver disease: a clinical review. , 2012, Annals of hepatology.

[11]  G. Daley,et al.  The promise of induced pluripotent stem cells in research and therapy , 2012, Nature.

[12]  S. Kopic,et al.  Calcium-Modulated Chloride Pathways Contribute to Chloride Flux in Murine Cystic Fibrosis-Affected Macrophages , 2011, Pediatric Research.

[13]  M. Pollheimer,et al.  Will we ever model PSC? - "it's hard to be a PSC model!". , 2011, Clinics and research in hepatology and gastroenterology.

[14]  P. Negulescu,et al.  Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809 , 2011, Proceedings of the National Academy of Sciences.

[15]  F. Nevens,et al.  Systematic review: the pathophysiology and management of polycystic liver disease , 2011, Alimentary pharmacology & therapeutics.

[16]  S. Ellard,et al.  Alagille syndrome: pathogenesis, diagnosis and management , 2011, European Journal of Human Genetics.

[17]  J. Clancy,et al.  Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation , 2011, Thorax.

[18]  L. Blomberg,et al.  Culture of porcine hepatocytes or bile duct epithelial cells by inductive serum-free media , 2011, In Vitro Cellular & Developmental Biology - Animal.

[19]  Ludovic Vallier,et al.  Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. , 2010, The Journal of clinical investigation.

[20]  L. Antiga,et al.  Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[21]  F. Lemaigre,et al.  Organogenesis and development of the liver. , 2010, Developmental cell.

[22]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.

[23]  P. Zelenka,et al.  Notch signaling is required for lateral induction of Jagged1 during FGF-induced lens fiber differentiation. , 2009, Developmental biology.

[24]  H. Deng,et al.  Derivation and Characterization of Hepatic Progenitor Cells from Human Embryonic Stem Cells , 2009, PloS one.

[25]  F. Tronche,et al.  Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated by the transcription factor SOX9. , 2009, Gastroenterology.

[26]  B. Stanger,et al.  Notch signaling controls liver development by regulating biliary differentiation , 2009, Development.

[27]  Pan Du,et al.  lumi: a pipeline for processing Illumina microarray , 2008, Bioinform..

[28]  F. Endo,et al.  FGF signaling segregates biliary cell‐lineage from chick hepatoblasts cooperatively with BMP4 and ECM components in vitro , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[29]  A. Bush,et al.  Cystic fibrosis , 2007, BMJ : British Medical Journal.

[30]  N. LaRusso,et al.  Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate. , 2007, Gastroenterology.

[31]  S. Bray.  Notch signalling: a simple pathway becomes complex , 2006, Nature Reviews Molecular Cell Biology.

[32]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[33]  S. Glaser,et al.  Bile acid interactions with cholangiocytes. , 2006, World journal of gastroenterology.

[34]  B. Ehrlich,et al.  Calcium signaling in cholangiocytes. , 2006, World journal of gastroenterology.

[35]  P. Courtoy,et al.  Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors. , 2005, Genes & development.

[36]  R. Carithers,et al.  Practice Guidelines : Evaluation of the Patient for Liver Transplantation , 2005 .

[37]  N. LaRusso,et al.  The cholangiopathies: disorders of biliary epithelia. , 2004, Gastroenterology.

[38]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[39]  N. LaRusso,et al.  Somatostatin stimulates ductal bile absorption and inhibits ductal bile secretion in mice via SSTR2 on cholangiocytes. , 2003, American journal of physiology. Cell physiology.

[40]  J. Boyer,et al.  Molecular identification and functional characterization of Mdr1a in rat cholangiocytes. , 2000, Gastroenterology.

[41]  S. Glaser,et al.  Functional heterogeneity of the intrahepatic biliary epithelium , 2000, Hepatology.

[42]  R. Kopito,et al.  Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. , 1994, The Journal of biological chemistry.

[43]  G. Fraedrich,et al.  Juvenile recurrent respiratory papillomatosis: Still a mystery disease with difficult management , 2007, Head & neck.

[44]  F. Accurso,et al.  Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation , 2012 .

[45]  C. Sempoux,et al.  AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE A Classification of Ductal Plate Malformations Based on Distinct Pathogenic Mechanisms of Biliary Dysmorphogenesis , 2011 .

[46]  J. Osterreicher,et al.  Expression of MRP2 and MDR1 transporters and other hepatic markers in rat and human liver and in WRL 68 cell line. , 2005, Physiological research.

[47]  N. LaRusso,et al.  Secretin induces the apical insertion of aquaporin-1 water channels in rat cholangiocytes. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[48]  W. Robinson,et al.  Pathogenesis, Diagnosis, and Management , 1996 .

[49]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .